Treatment for Type 2 Diabetes Mellitus

Phase-Based Progress Estimates

Effectiveness

Safety

Johns Hopkins Pediatric Diabetes Center, Baltimore, MD

Type 2 Diabetes Mellitus+4 More

You have a chance of qualifying for this trial. We made sure your application will take less than 5 minutes.

Eligibility

< 65

All Sexes

What conditions do you have?

Select

Eligibility

< 65

All Sexes

What conditions do you have?

Select

Study Summary

The purpose of this study is to determine if use of a nonmydriatic fundus camera using autonomous artificial intelligence software at the point of care increases the proportion of underserved youth with diabetes screened for diabetic retinopathy.

Eligible Conditions

Type 2 Diabetes Mellitus
Diabetes Related Cystic Fibrosis
Type 1 Diabetes Mellitus

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Type 2 Diabetes Mellitus

Glucagon-like peptide-1

Potato Starch (Bob's Red Mill)

MB-102 and Zeiss FF450 fundus camera

Study Objectives

1 Primary · 1 Secondary · Reporting Duration: 2 years

2 years

Percentage of agreement in interpretation of retinal images

Proportion screened for diabetic retinopathy

Trial Safety

Safety Progress

1 of 3

Other trials for Type 2 Diabetes Mellitus

Glucagon-like peptide-1

Potato Starch (Bob's Red Mill)

MB-102 and Zeiss FF450 fundus camera

Trial Design

0 Treatment Group

500 Total Participants · 0 Treatment Group

Primary Treatment: Treatment · No Placebo Group · N/A

Trial Logistics

Trial Timeline

Approximate Timeline

Screening: ~3 weeks

Treatment: Varies

Reporting: 2 years

Closest Location: Johns Hopkins Pediatric Diabetes Center · Baltimore, MD

2022First Recorded Clinical Trial

3 TrialsResearching Type 2 Diabetes Mellitus

2 CompletedClinical Trials

Who is running the clinical trial?

National Eye Institute (NEI)NIH

514 Previous Clinical Trials

1,073,575 Total Patients Enrolled

2 Trials studying Type 2 Diabetes Mellitus

2,308 Patients Enrolled for Type 2 Diabetes Mellitus

Johns Hopkins UniversityLead Sponsor

2,033 Previous Clinical Trials

30,781,875 Total Patients Enrolled

11 Trials studying Type 2 Diabetes Mellitus

1,072 Patients Enrolled for Type 2 Diabetes Mellitus

Risa M Wolf, MDPrincipal InvestigatorJohns Hopkins University

1 Previous Clinical Trials

41 Total Patients Enrolled

1 Trials studying Type 2 Diabetes Mellitus

41 Patients Enrolled for Type 2 Diabetes Mellitus

Eligibility Criteria

Age < 65 · All Participants · 2 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

You have Type 2 diabetes.

About The Reviewer

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

References